Vitamin D activation pathways in inflammation and bone health uncovered

23383975-1cb8-4bb1-a275-3766ede22da3articleimage.jpg

17 Oct 2017 --- Researchers have identified a region of the genome that regulates vitamin D activation in the kidneys, opening the door for more sophisticated treatments of diseases, including bone and immune disorders, involving vitamin D. The results of this research will be published in the October 20 issue of the Journal of Biological Chemistry.

Vitamin D is essential for building bones, the American Society for Biochemistry and Molecular Biology (ASBMB) press release notes. Inactive vitamin D obtained from the diet or produced in the skin is converted to its active form, calcitriol, in the kidneys.

Calcitriol can also be produced in other parts of the body, including skin cells and immune cells. In these non-kidney sites, calcitriol seems to serve a completely different purpose: it appears to play no role in regulation of minerals, and its production is induced by inflammation rather than by the hormones that control calcitriol synthesis in the kidneys.

Understanding the function of non-kidney calcitriol production and its connection to inflammatory diseases, ranging from multiple sclerosis to arthritis, is of great interest to a number of biomedical researchers, who would like to know whether and how vitamin D could potentially be used to treat these diseases.

However, research in this area has not been helped by the inability to separately study the pathways controlling kidney and non-kidney vitamin D activation.

Engineering helps focus on vitamin D activation
A group of researchers at the University of Wisconsin, overseen by J. Wesley Pike, have now overcome this hurdle by using CRISPR/Cas engineering to produce mice with kidney-specific control of vitamin D activation.

“Through the creation of these mice, we can turn off endocrine regulation of [calcitriol] production exclusively in the kidney,” says Mark Meyer, the research associate who led the new study. “By doing so, we can focus further on the inflammatory regulation of [calcitriol].”

Calcitriol production is carried out by the enzyme CYP27B1, but the genomic regions that the team deleted in the experimental mice are far away from the gene encoding this enzyme. Rather, the researchers deleted what's known as enhancer regions for the Cyp27b1 gene. These regions of DNA bind to specific proteins controlled by the hormones involved in vitamin D regulation, causing the genomic DNA to rearrange in a way that enhances production of CYP27B1.

Importantly, deleting these regions affected the response of vitamin D activation to hormones, but not to inflammation-related molecules, indicating that these regions were key to allowing researchers to separately study the two types of calcitriol production.

While the long-term goal of the team is to understand the function of calcitriol in inflammatory diseases, identifying the kidney-specific enhancer region of the genome is already yielding insights into the mechanisms involved in bone disorders.

Meyer describes the work of a clinician collaborator who, in aiming to understand pediatric skeletal disorders, is examining his patients for mutations in the same enhancer regions identified in the mice.

“That [information] might be able to tell that particular clinician about which treatment course might be most appropriate for that individual,” Meyer says. For example, many skeletal disorders are treated with calcium and vitamin D supplements, but patients with mutations in regions involved in vitamin D regulation might actually be harmed by calcium supplementation.

The ASBMB study is the latest to confirm the benefits of vitamin D. The versatile vitamin has been linked to better child development and improved public health in Ireland.

Vitamin D was also a hot topic at Vitafoods 2017 during a discussion of “silver consumers,” and recent product launches with the vitamin include Cambridge Commodities’ VitaShroom mushroom-based vitamin D powder. 

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Protein provides benefit for adult bone and joint health, expert consensus reports

17 May 2018 --- Dietary protein intake above the recommended levels may help reduce bone loss and fracture risk in seniors with osteoporosis, an expert consensus reports. Based on an analysis of major research studies, the review, published in Osteoporosis International, found that a protein-rich diet is beneficial for adult bone health. The consensus debunks the popular myth that too much protein may be damaging to bone health.

Nutrition & Health News

Vitamin D may play a role in children's non-alcoholic liver disease, study finds

15 May 2018 --- Children with non-alcoholic fatty liver disease (NAFLD) have particularly low vitamin D status and suffer from vitamin D insufficiency throughout the year, new research has found. The research, published in Pediatric Obesity, charted vitamin D levels and variations in genes that determine vitamin D status, in British children diagnosed with the liver disease. The findings open up potential future possibilities for treatment using vitamin D.

Nutrition & Health News

One gram of fish oil a day to keep osteoarthritis pain at bay, study suggests

10 May 2018 --- One gram of fish oil a day could help reduce the pain of patients with osteoarthritis, a new study in Rheumatology reports. In the largest, most up to date study of its kind, researchers from the University of Surrey examined the link between diet and the effective self-management of osteoarthritis.

Nutrition & Health News

Frutarom: Echinacea's immune-boosting benefits backed by trials

07 May 2018 --- Echishield, an all-natural Echinacea ingredient produced by Frutarom Health, enhances immune function by restoring stress-induced changes to levels similar to those in healthy controls, a study has found. The ingredient is water-soluble, safe and suitable for supplement, beverage and confectionary applications.

Nutrition & Health News

Kellogg’s: Special K strengthens health standing in snacking with snack-bar revamp

04 May 2018 --- Kellogg’s Special K bars are packing more of a health punch following a revamp to make the bars bigger, pack wholegrain oats and whole fruit pieces and, to be fortified with vitamins B3, B6 and folic acid. This move comes amid a chain of health orientated, product transformations under the Kellogg’s Better Starts plan. For example, the sugar in Coco Pops will be reduced from 30g to 17g per 100g, Rice Krispies salt levels have been reduced by 10 percent, all children's promotions have been removed from Frosties cereal packaging and all Kellog’s cereals now carry 50 percent of people’s daily vitamin D needs.

More Articles
URL : http://www.nutritioninsight.com:80/news/vitamin-d-activation-pathways-in-inflammation-and-bone-health-uncovered.html